Celona logo_RGB.jpg
Celona Extends Zero Trust Security to Private 4G/5G Networks With Palo Alto Networks
05 janv. 2024 10h12 HE | Celona
Celona extends zero trust security to private 4G/5G networks with Palo Alto Networks integration
New Logo.png
Provectus Biopharmaceuticals Receives Notice of Allowance for Refractory Pediatric Solid Tumor Cancer Monotherapy and Combination Therapy Patent for PV-10® Immunotherapy from United States Patent and Trademark Office
23 mars 2021 07h00 HE | Provectus Biopharmaceuticals Inc.
KNOXVILLE, TN, March 23, 2021 (GLOBE NEWSWIRE) -- Provectus (OTCQB: PVCT) today announced that the United States Patent and Trademark Office (USPTO) has allowed US patent application 16/412,872,...